TravisWDCostabelUHansellDM. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733-748.
2.
NaranjoCABustoUSellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
3.
LeeEJLeeSYInKHKimCHParkS. Organizing pneumonia associated with oxaliplatin-combined chemotherapy: a case report. Med Princ Pract. 2012;21:89-92.
4.
VasuTSCavallazziRHiraniASharmaDWeibelSBKaneGC. Clinical and radiologic distinctions between secondary bronchiolitis obliterans organizing pneumonia and cryptogenic organizing pneumonia. Respir Care. 2009;54:1028-1032.
5.
VahidBMarikPE. Pulmonary complications of novel antineoplastic agents for solid tumors. Chest. 2008;133:528-538.